Global Biologics and Biosimilars Market Report 2023
- Report Code : BIS2375112
- Published On: Jun, 2021
- Category : Chemicals & Materials
- Pages : 120
-
At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide were infected with COVID-19 disease, and major countries around the world have implemented foot prohibitions and work stoppage orders. Except for the medical supplies and life support products industries, most industries have been greatly impacted, and Biologics and Biosimilars industries have also been greatly affected.
In the past few years, the Biologics and Biosimilars market experienced a growth of 0.177635272784, the global market size of Biologics and Biosimilars reached 3072.0 million $ in 2020, of what is about 1881.0 million $ in 2015.
From 2015 to 2019, the growth rate of global Biologics and Biosimilars market size was in the range of xxx%. At the end of 2019, COVID-19 began to erupt in China, Due to the huge decrease of global economy; we forecast the growth rate of global economy will show a decrease of about 4%, due to this reason, Biologics and Biosimilars market size in 2020 will be 3072.0 with a growth rate of xxx%. This is xxx percentage points lower than in previous years.
As of the date of the report, there have been more than 20 million confirmed cases of CVOID-19 worldwide, and the epidemic has not been effectively controlled. Therefore, we predict that the global epidemic will be basically controlled by the end of 2020 and the global Biologics and Biosimilars market size will reach 4575.0 million $ in 2025, with a CAGR of xxx% between 2020-2025.
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.
Section 1: Free——Definition
Section (2 3): 1200 USD——Manufacturer Detail
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
Section 4: 900 USD——Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7): 500 USD——
Product Type Segmentation
Antibody
Hormone
Growth Factors
Other
Industry Segmentation
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Channel (Direct Sales, Distributor) Segmentation
Section 8: 400 USD——Trend (2020-2025)
Section 9: 300 USD——Product Type Detail
Section 10: 700 USD——Downstream Consumer
Section 11: 200 USD——Cost Structure
Section 12: 500 USD——Conclusion
-
With tables and figures helping analyze worldwide Global Biologics and Biosimilars market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Section 1 Biologics and Biosimilars Product Definition
Section 2 Global Biologics and Biosimilars Market Manufacturer Share and Market Overview2.1 Global Manufacturer Biologics and Biosimilars Shipments
2.2 Global Manufacturer Biologics and Biosimilars Business Revenue
2.3 Global Biologics and Biosimilars Market Overview
2.4 COVID-19 Impact on Biologics and Biosimilars Industry
Section 3 Manufacturer Biologics and Biosimilars Business Introduction3.1 Roche Biologics and Biosimilars Business Introduction
3.1.1 Roche Biologics and Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
3.1.2 Roche Biologics and Biosimilars Business Distribution by Region
3.1.3 Roche Interview Record
3.1.4 Roche Biologics and Biosimilars Business Profile
3.1.5 Roche Biologics and Biosimilars Product Specification3.2 Amgen Biologics and Biosimilars Business Introduction
3.2.1 Amgen Biologics and Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
3.2.2 Amgen Biologics and Biosimilars Business Distribution by Region
3.2.3 Interview Record
3.2.4 Amgen Biologics and Biosimilars Business Overview
3.2.5 Amgen Biologics and Biosimilars Product Specification3.3 AbbVie Biologics and Biosimilars Business Introduction
3.3.1 AbbVie Biologics and Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
3.3.2 AbbVie Biologics and Biosimilars Business Distribution by Region
3.3.3 Interview Record
3.3.4 AbbVie Biologics and Biosimilars Business Overview
3.3.5 AbbVie Biologics and Biosimilars Product Specification3.4 Sanofi-Aventis Biologics and Biosimilars Business Introduction
3.5 Johnson & Johnson Biologics and Biosimilars Business Introduction
3.6 Pfizer Biologics and Biosimilars Business Introduction
…
Section 4 Global Biologics and Biosimilars Market Segmentation (Region Level)4.1 North America Country
4.1.1 United States Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.1.2 Canada Biologics and Biosimilars Market Size and Price Analysis 2015-20204.2 South America Country
4.2.1 South America Biologics and Biosimilars Market Size and Price Analysis 2015-20204.3 Asia Country
4.3.1 China Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.3.2 Japan Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.3.3 India Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.3.4 Korea Biologics and Biosimilars Market Size and Price Analysis 2015-20204.4 Europe Country
4.4.1 Germany Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.4.2 UK Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.4.3 France Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.4.4 Italy Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.4.5 Europe Biologics and Biosimilars Market Size and Price Analysis 2015-20204.5 Other Country and Region
4.5.1 Middle East Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.5.2 Africa Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.5.3 GCC Biologics and Biosimilars Market Size and Price Analysis 2015-20204.6 Global Biologics and Biosimilars Market Segmentation (Region Level) Analysis 2015-2020
4.7 Global Biologics and Biosimilars Market Segmentation (Region Level) Analysis
Section 5 Global Biologics and Biosimilars Market Segmentation (Product Type Level)5.1 Global Biologics and Biosimilars Market Segmentation (Product Type Level) Market Size 2015-2020
5.2 Different Biologics and Biosimilars Product Type Price 2015-2020
5.3 Global Biologics and Biosimilars Market Segmentation (Product Type Level) Analysis
Section 6 Global Biologics and Biosimilars Market Segmentation (Industry Level)6.1 Global Biologics and Biosimilars Market Segmentation (Industry Level) Market Size 2015-2020
6.2 Different Industry Price 2015-2020
6.3 Global Biologics and Biosimilars Market Segmentation (Industry Level) Analysis
Section 7 Global Biologics and Biosimilars Market Segmentation (Channel Level)7.1 Global Biologics and Biosimilars Market Segmentation (Channel Level) Sales Volume and Share 2015-2020
7.2 Global Biologics and Biosimilars Market Segmentation (Channel Level) Analysis
Section 8 Biologics and Biosimilars Market Forecast 2020-20258.1 Biologics and Biosimilars Segmentation Market Forecast (Region Level)
8.2 Biologics and Biosimilars Segmentation Market Forecast (Product Type Level)
8.3 Biologics and Biosimilars Segmentation Market Forecast (Industry Level)
8.4 Biologics and Biosimilars Segmentation Market Forecast (Channel Level)
Section 9 Biologics and Biosimilars Segmentation Product Type9.1 Antibody Product Introduction
9.2 Hormone Product Introduction
9.3 Growth Factors Product Introduction
9.4 Other Product Introduction
Section 10 Biologics and Biosimilars Segmentation Industry10.1 Tumor Clients
10.2 Diabetes Clients
10.3 Cardiovascular Clients
10.4 Hemophilia Clients
10.5 Other Clients
Section 11 Biologics and Biosimilars Cost of Production Analysis11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview
Section 12 Conclusion
Chart and Figure
Figure Biologics and Biosimilars Product Picture from Roche
Chart 2015-2020 Global Manufacturer Biologics and Biosimilars Shipments (Units)
Chart 2015-2020 Global Manufacturer Biologics and Biosimilars Shipments Share
Chart 2015-2020 Global Manufacturer Biologics and Biosimilars Business Revenue (Million USD)
Chart 2015-2020 Global Manufacturer Biologics and Biosimilars Business Revenue Share
Chart Roche Biologics and Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
Chart Roche Biologics and Biosimilars Business Distribution
Chart Roche Interview Record (Partly)
Figure Roche Biologics and Biosimilars Product Picture
Chart Roche Biologics and Biosimilars Business Profile
Table Roche Biologics and Biosimilars Product Specification
Chart Amgen Biologics and Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
Chart Amgen Biologics and Biosimilars Business Distribution
Chart Amgen Interview Record (Partly)
Figure Amgen Biologics and Biosimilars Product Picture
Chart Amgen Biologics and Biosimilars Business Overview
Table Amgen Biologics and Biosimilars Product Specification
Chart AbbVie Biologics and Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
Chart AbbVie Biologics and Biosimilars Business Distribution
Chart AbbVie Interview Record (Partly)
Figure AbbVie Biologics and Biosimilars Product Picture
Chart AbbVie Biologics and Biosimilars Business Overview
Table AbbVie Biologics and Biosimilars Product Specification3.4 Sanofi-Aventis Biologics and Biosimilars Business Introduction
…
Chart United States Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart United States Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart Canada Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Canada Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart South America Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart South America Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart China Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart China Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart Japan Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Japan Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart India Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart India Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart Korea Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Korea Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart Germany Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Germany Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart UK Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart UK Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart France Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart France Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart Italy Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Italy Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart Europe Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Europe Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart Middle East Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Middle East Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart Africa Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Africa Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart GCC Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart GCC Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart Global Biologics and Biosimilars Market Segmentation (Region Level) Sales Volume 2015-2020
Chart Global Biologics and Biosimilars Market Segmentation (Region Level) Market size 2015-2020
Chart Biologics and Biosimilars Market Segmentation (Product Type Level) Volume (Units) 2015-2020
Chart Biologics and Biosimilars Market Segmentation (Product Type Level) Market Size (Million $) 2015-2020
Chart Different Biologics and Biosimilars Product Type Price ($/Unit) 2015-2020
Chart Biologics and Biosimilars Market Segmentation (Industry Level) Market Size (Volume) 2015-2020
Chart Biologics and Biosimilars Market Segmentation (Industry Level) Market Size (Share) 2015-2020
Chart Biologics and Biosimilars Market Segmentation (Industry Level) Market Size (Value) 2015-2020
Chart Global Biologics and Biosimilars Market Segmentation (Channel Level) Sales Volume (Units) 2015-2020
Chart Global Biologics and Biosimilars Market Segmentation (Channel Level) Share 2015-2020
Chart Biologics and Biosimilars Segmentation Market Forecast (Region Level) 2020-2025
Chart Biologics and Biosimilars Segmentation Market Forecast (Product Type Level) 2020-2025
Chart Biologics and Biosimilars Segmentation Market Forecast (Industry Level) 2020-2025
Chart Biologics and Biosimilars Segmentation Market Forecast (Channel Level) 2020-2025
Chart Antibody Product Figure
Chart Antibody Product Advantage and Disadvantage Comparison
Chart Hormone Product Figure
Chart Hormone Product Advantage and Disadvantage Comparison
Chart Growth Factors Product Figure
Chart Growth Factors Product Advantage and Disadvantage Comparison
Chart Other Product Figure
Chart Other Product Advantage and Disadvantage Comparison
Chart Tumor Clients
Chart Diabetes Clients
Chart Cardiovascular Clients
Chart Hemophilia Clients
Chart Other Clients
-
The Global Biologics and Biosimilars Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Companies in the Global Biologics and Biosimilars Industry will need to adapt swiftly to the behavioral changes that are reshaping consumer decision journeys.
In recent years, the Global Biologics and Biosimilars Market has grown at an incredible rate. From 2025 to 2030, the market is expected to grow at a CAGR of yy%.
The influx of capital into the Global Biologics and Biosimilars Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
The latest version of the Global Biologics and Biosimilars Market study includes a market size breakdown by relevant business segments, applications, and geography, as well as qualitative insights such as Patent Analysis*, Market Entropy, Key Development Activities, Market Dynamics, PEST and PORTER models, and more.
